115 related articles for article (PubMed ID: 14698657)
1. Lipopolysaccharide attenuates thrombolysis in batroxobin-induced lung vasculature fibrin deposition but not in ferrous chloride-induced carotid artery thrombus in rats: role of endogenous PAI-1.
Wang YX; Dong N; Wu C; Martin-McNulty B; Fitch RM; da Cunha V; Vicelette J; Tran K; Vergona R; Sullivan ME; Morser J; Wu Q
Thromb Res; 2003; 111(6):381-7. PubMed ID: 14698657
[TBL] [Abstract][Full Text] [Related]
2. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
[TBL] [Abstract][Full Text] [Related]
3. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
[TBL] [Abstract][Full Text] [Related]
4. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
Lenfors S; Gustafsson D
Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Zhu Y; Carmeliet P; Fay WP
Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
[TBL] [Abstract][Full Text] [Related]
6. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
[TBL] [Abstract][Full Text] [Related]
7. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
8. Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury.
Chen Y; Lu ZJ; Yang Y; Lu GP; Chen WM; Zhang LE
Thromb Res; 2015 Jul; 136(1):131-8. PubMed ID: 25934465
[TBL] [Abstract][Full Text] [Related]
9. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis.
van Giezen JJ; Wahlund G; Nerme ; Abrahamsson T
Thromb Haemost; 1997 May; 77(5):964-9. PubMed ID: 9184411
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H
Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607
[TBL] [Abstract][Full Text] [Related]
11. The significance of fibrin binding by plasminogen activator inhibitor 1 for the mechanism of tissue-type plasminogen activator-mediated fibrinolysis.
Stringer HA; Pannekoek H
J Biol Chem; 1995 May; 270(19):11205-8. PubMed ID: 7744752
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion.
Schoots IG; Levi M; van Vliet AK; Declerck PJ; Maas AM; van Gulik TM
Thromb Haemost; 2004 Mar; 91(3):497-505. PubMed ID: 14983225
[TBL] [Abstract][Full Text] [Related]
15. Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure.
Wang Y; Pratt JR; Hartley B; Evans B; Zhang L; Sacks SH
Kidney Int; 1997 Aug; 52(2):371-7. PubMed ID: 9263992
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
Nagashima M; Werner M; Wang M; Zhao L; Light DR; Pagila R; Morser J; Verhallen P
Thromb Res; 2000 May; 98(4):333-42. PubMed ID: 10822080
[TBL] [Abstract][Full Text] [Related]
19. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
20. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
Cao YJ; Wu YH; Liu CF
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]